Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.

BACKGROUND Alzheimer's disease (AD) and frontotemporal dementia (FTD) are leading causes of cognitive decline. Optical coherence tomography (OCT) allows the measurement of thickness of retinal neuroaxonal layers. While in AD and mild cognitive impairment (MCI), retinal nerve fiber layer (RNFL) thinning is frequently reported, less information is available on ganglion cell layer-inner plexiform layer (GCL-IPL). Data on FTD are lacking. OBJECTIVE To obtain cross-sectional information on RNFL and GCL-IPL thickness among MCI, AD, FTD, and healthy controls (HC), and their correlations with dementia severity. METHODS Peripapillary OCT scans were obtained in 27 MCI, 39 AD, 17 FTD, 49 HC using high-definition Heidelberg Spectral-domain OCT, with RNFL and GCL-IPL thickness measurement. Statistical analysis tested group effects and correlation with gender, disease duration and severity (Mini-Mental State Examination, MMSE). RESULTS RNFL showed a significant group effect [F(4,132) = 3.786, p = 0.006], being reduced versus controls in MCI (p = 0.033), moderate AD (p = 0.025), and FTD (p < 0.001), and versus mild AD in FTD (p = 0.042). GCL-IPL showed a significant group effect as well [F(4,121) = 5.104, p < 0.001], with reduction in moderate AD versus HC (p < 0.001), MCI (p = 0.037), and mild AD (p = 0.009); in FTD versus HC (p = 0.002) and mild AD (p = 0.038). In AD, GCL-IPL correlated with MMSE (r = 0.487, p = 0.003), without significant effects of age, gender, or disease duration. CONCLUSION Retinal neuroaxonal thinning occurs in MCI/AD consistently with previous reports, as well as in FTD. Correlation with disease severity in AD suggests that retinal and brain neurodegeneration may occur in parallel to some extent, and prompts larger studies aimed at providing surrogate endpoints for clinical trials in AD.

[1]  Philip Scheltens,et al.  Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges , 2015, Journal of Alzheimer's disease : JAD.

[2]  Francesco Pierelli,et al.  Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis , 2015, PloS one.

[3]  J. Jolles,et al.  Visuospatial processing in early Alzheimer’s disease: A multimodal neuroimaging study , 2015, Cortex.

[4]  Seray Aslan Bayhan,et al.  Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral‐domain optical coherence tomography , 2015, Clinical & experimental ophthalmology.

[5]  U. Can,et al.  The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness , 2015, Neurological Sciences.

[6]  Robert V Farese,et al.  Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD , 2014, The Journal of experimental medicine.

[7]  Raul Lopez-Anton,et al.  Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study , 2014, Journal of Neurology.

[8]  J. Salazar,et al.  Macular thickness as a potential biomarker of mild Alzheimer's disease. , 2014, Ophthalmology.

[9]  Giovanni Staurenghi,et al.  Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. , 2013, Investigative ophthalmology & visual science.

[10]  Murray Grossman,et al.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration , 2013, International review of psychiatry.

[11]  Serkan Kirbas,et al.  Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[12]  C. Rowe,et al.  Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease , 2013, Translational Psychiatry.

[13]  Richard A Armstrong,et al.  Statistical guidelines for the analysis of data obtained from one or both eyes , 2013, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[14]  T. Wong,et al.  Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  James E. Morgan,et al.  Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease , 2012, Neurobiology of Aging.

[16]  Amos D. Korczyn,et al.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2011, Clinical Neurology and Neurosurgery.

[17]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[18]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[19]  Daniel L. Farkas,et al.  Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.

[20]  Xinqing Zhang,et al.  Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography , 2010, Neuroscience Letters.

[21]  K. Ashe,et al.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.

[22]  Claire Paquet,et al.  Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2007, Neuroscience Letters.

[23]  Fatmire Berisha,et al.  Retinal abnormalities in early Alzheimer's disease. , 2007, Investigative ophthalmology & visual science.

[24]  N. Yüksel,et al.  Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[25]  H. Chertkow,et al.  Visual Retinocortical Function in Dementia of the Alzheimer Type , 2002, Gerontology.

[26]  R A Armstrong,et al.  Visual Field Defects in Alzheimer’s Disease Patients May Reflect Differential Pathology in the Primary Visual Cortex , 1996, Optometry and vision science : official publication of the American Academy of Optometry.

[27]  R. Blanks,et al.  Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL , 1996, Neurobiology of Aging.

[28]  R. Blanks,et al.  Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina , 1996, Neurobiology of Aging.

[29]  S. Corkin,et al.  Prevalence of visual deficits in Alzheimer's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.

[30]  L R Trick,et al.  Visual field loss in senile dementia of the Alzheimer's type , 1995, Neurology.

[31]  J. Fujimoto,et al.  Optical Coherence Tomography , 1991, LEOS '92 Conference Proceedings.

[32]  V. Iragui,et al.  Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration? , 1989, Annals of neurology.

[33]  C. Miller,et al.  Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.

[34]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[35]  Ying Liu,et al.  Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease. , 2015, Archives of gerontology and geriatrics.

[36]  F. D’Antonio,et al.  Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. , 2014, Journal of Alzheimer's disease : JAD.

[37]  Julián Benito-León,et al.  Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[38]  M. Schwartz,et al.  The retina as a window to the brain—from eye research to CNS disorders , 2013, Nature Reviews Neurology.